Shopping Cart
Remove All
Your shopping cart is currently empty
TAK-448 acetate (MVT-602 acetate) is a synthetic peptide and small molecule KISS1R agonist with antitumor activity. It inhibits the proliferation of VCaP cells and is useful in prostate cancer research.

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 1 mg | $98 | - | In Stock | |
| 5 mg | $247 | - | In Stock | |
| 10 mg | $396 | - | In Stock | |
| 25 mg | $648 | - | In Stock | |
| 50 mg | $912 | - | In Stock |
| Description | TAK-448 acetate (MVT-602 acetate) is a synthetic peptide and small molecule KISS1R agonist with antitumor activity. It inhibits the proliferation of VCaP cells and is useful in prostate cancer research. |
| Targets&IC50 | KISS1R:632 pM, KISS1R:460 pM |
| In vivo | A single injection of TAK-448 significantly increases plasma levels of follicle-stimulating hormone and testosterone (T) in male rats. In the androgen-sensitive prostate cancer model of male rats with VCaP xenografts, TAK-448 (0.01, 0.03, 0.3, 3 mg/kg; i.h.; 0,28 days) exhibits greater anti-tumor effects[1]. |
| Synonyms | TAK-448 acetate (1234319-68-6 Free base), MVT-602 acetate |
| Molecular Weight | 1285.41 |
| Formula | C60H84N16O16 |
| Cas No. | 1470374-22-1 |
| Smiles | CC(O)=O.CNC(=N)NCCC[C@H](NC(=O)[C@H](CC(C)C)NC(=O)NNC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H]1C[C@@H](O)CN1C(=O)[C@@H](Cc1ccc(O)cc1)NC(C)=O)[C@@H](C)O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(N)=O |
| Relative Density. | no data available |
| Color | White |
| Appearance | Solid |
| Sequence | Ac-{d-Tyr}-{Hyp}-NTF-{Aza-Gly}-L-{Arg(Me)}-W-NH2 |
| Storage | keep away from moisture | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||||||||||||
| Solubility Information | DMSO: 80 mg/mL (62.24 mM), Sonication is recommended. H2O: 30 mg/mL (23.34 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
| In Vivo Formulation | 10% DMSO+40% PEG300+5% Tween 80+45% Saline: 3.3 mg/mL (2.57 mM), Sonication is recommended. Please add the solvents sequentially, clarifying the solution as much as possible before adding the next one. Dissolve by heating and/or sonication if necessary. Working solution is recommended to be prepared and used immediately. The formulation provided above is for reference purposes only. In vivo formulations may vary and should be modified based on specific experimental conditions. | |||||||||||||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||||||||||||
H2O/DMSO
DMSO
| ||||||||||||||||||||||||||||||||||||
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.